Femasys (FEMY) EPS (Weighted Average and Diluted) Growth (1y) (2021 - 2025)
Femasys (FEMY) EPS (Weighted Average and Diluted) Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 18.75% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -203.74% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 10.48% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 56.10% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -190.91% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 23.62% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -112.00% |
| 10 | Femasys | 254.59 Mn | 249.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 23.81% |
| Mar 31, 2025 | -35.29% |
| Dec 31, 2024 | -21.05% |
| Sep 30, 2024 | 7.69% |
| Jun 30, 2024 | 4.55% |
| Mar 31, 2024 | 32.00% |
| Dec 31, 2023 | 20.83% |
| Sep 30, 2023 | -4.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | -4.17% |
| Dec 31, 2022 | -200.00% |
| Sep 30, 2022 | -31.58% |
| Jun 30, 2022 | 57.69% |
| Mar 31, 2022 | 86.96% |
| Dec 31, 2021 | 95.29% |
| Sep 30, 2021 | 88.41% |
| Jun 30, 2021 | 66.45% |